Navigation Links
Applied Protein Sciences Acquired by IndUS Pharmaceuticals
Date:6/10/2013

Mountain View, CA (PRWEB) June 10, 2013

Applied Protein Sciences (APS), a privately held biotech company founded in 2007 in Mountain View, CA, announces that it has been acquired by IndUS Pharmaceuticals (IndUS), a privately held Boston based pharmaceutical company.

The acquisition gives IndUS the ability to extend its pipeline to include preclinical stage molecules for the treatment of Oral Mucositis, a severe unmet medical need for cancer patients. APS has shown significant efficacy in the prevention and treatment of oral mucositis (OM) in several animal models. Specifically, APS demonstrated a 45% reduction in the number of cases of severe and moderate mucositis, which translates to significantly lower hospitalization rates. The preclinical candidates also have potential for the treatment of unmet medical needs such as GI mucositis, inflammatory bowel disease (IBD) and proctitis. APS drug molecules, their use and synthesis is protected by an extensive patent portfolio, including currently 6 issued US patents.

Aman Johar, co-founder of APS said, “APS preclinical candidates have shown the potential to make cancer treatments more effective and IndUS is the right partner to take the drug candidates through the development cycle.” Funding for the pre-clinical studies was provided by Innovation Management Sciences (IMSciences), a private investment firm that specializes in technology companies with strong intellectual property portfolios. Pravin Chaturvedi, CEO of IndUS said “the addition of these molecules provides IndUS with an exciting opportunity to develop and commercialize novel oral mucositis treatments to address acute unmet medical needs in cancer radiation and/or chemotherapy.”

IndUS and its Indian affiliate Sindu Research Laboratories Private Limited, a drug discovery company, are developing several novel pyrrolobenzodiazepine dimers (PBDs) for the treatment of various hematologic and solid cancers. IndUS also has exclusive access to evaluate and license new chemical entities (NCEs) discovered in premier research institutes in India for use in the treatment of cancer, diabetes and infectious diseases.

For more information please visit: http://www.induspharm.com and http://www.appliedprotein.com

Read the full story at http://www.prweb.com/releases/AppliedProtein/IndUS/prweb10797440.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Applied nanobiomedicine: Exploiting nanoparticles to hunt for hidden cancer cells
2. To Meet Growing Demand for Sports Psychology Experts, Wexford University Offers Master’s Degree in Applied Sport Psychology: Classes Begin April 1
3. Spring Classes for Wexford University’s Online Doctoral Degree in Applied Sport Psychology Begin April 1
4. New Research Says Topically Applied L-Carnitine Effective in Treating Oily Skin
5. Fourth Annual Georgia Partnership for Telehealth, Inc. Conference, Impacting Lives Through Applied Technology, to be held March 18-20th 2013 in Savannah, Georgia
6. Wexford University Spring Classes for Online Doctoral Degree in Applied Sport Psychology Begin April 1
7. John Mitchell Re-Joins Applied Marketing Science
8. Charity Navigator Awards the Mesothelioma Applied Research Foundation with 4-Star Rating
9. The Mesothelioma Applied Research Foundation Opened its 2013 Grant Cycle
10. Applied Research Associates Remembers Tim Samaras
11. Warwick scientists uncover how checkpoint proteins bind chromosomes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... The ... demand of today’s consumer and regulatory authorities worldwide. From Children’s to Adults 50+, ... to meet the highest standard. , These products are also: Gluten Free, ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical ... Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. ... honor of Morris F. Collen, a pioneer in the field of medical informatics, this ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... , ... October 12, 2017 , ... HMP , ... recipient of a 2017 Folio Magazine Eddie Digital Award for ‘Best B-to-B Healthcare Website.’ ... on October 11, 2017. , The annual award competition recognizes editorial and design excellence ...
(Date:10/12/2017)... ... 2017 , ... On Saturday, October 21, the Health & Wellness Center at ... raise money for the American Heart Association Heart Walk. Teams of up to 10 ... to keep their treadmills moving for 5 hours. Treadmills will start at 7:00 p.m. ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)...  True Health, a leader in integrated diagnostics ... National Breast Cancer Awareness month to educate doctors ... Research recently published in ... than 10 million American women are at significant ... BRCA2 and have not had testing. These mutations can ...
(Date:10/5/2017)...  In response to the nationwide opioid epidemic, ... (AAOMS) released prescribing recommendations that urge ibuprofen – ... a first-line therapy to manage a patient,s acute ... Recognizing the value and importance of the ... Acute and Postoperative Pain Management" stresses that practitioners ...
(Date:10/2/2017)... INDIANAPOLIS , Oct. 2, 2017  Eli Lilly ... its financial results for the third quarter of 2017 ... a conference call on that day with the investment ... performance. The conference call will begin at ... public can access a live webcast of the conference ...
Breaking Medicine Technology: